Cyclophosphamide
NDC 65219-133, cyclophosphamide, injection, powder, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-133
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS, ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204555
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOPHOSPHAMIDE2 g/100mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-133-20 | 65219013320 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-133-20) / 100 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/31986d36-a1bf-4903-93a4-ce7386241ba1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-133
Use it
Look up 65219-133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.